BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 34665703)

  • 21. Clinical significance of anti-SSA/Ro antibody in Neuromyelitis optica spectrum disorders.
    Lin L; Hang H; Zhang J; Lu J; Chen D; Shi J
    Mult Scler Relat Disord; 2022 Feb; 58():103494. PubMed ID: 35051897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Usefulness of antibodies and minor salivary gland biopsy in the study of sicca syndrome in daily clinical practice.
    Santiago ML; Seisdedos MR; Garcia Salinas RN; Catalán Pellet A; Villalón L; Secco A
    Reumatol Clin; 2015; 11(3):156-60. PubMed ID: 25579246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interstitial lung disease in non-sicca onset primary Sjögren's syndrome: a large-scale case-control study.
    Gao H; Zou YD; Zhang XW; He J; Zhang J; Sun Y; Li ZG
    Int J Rheum Dis; 2018 Jul; 21(7):1423-1429. PubMed ID: 29968329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Obstetric and perinatal outcome in anti-Ro/SSA-positive pregnant women: a prospective cohort study.
    Martínez-Sánchez N; Pérez-Pinto S; Robles-Marhuenda Á; Arnalich-Fernández F; Martín Cameán M; Hueso Zalvide E; Bartha JL
    Immunol Res; 2017 Apr; 65(2):487-494. PubMed ID: 28138914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Significance of anti-La/SSB antibodies in primary Sjögren's syndrome patients with combined positivity for anti-Ro/SSA and salivary gland biopsy.
    Cafaro G; Perricone C; Baldini C; Quartuccio L; Priori R; Carubbi F; Ferro F; Colafrancesco S; Bini V; De Vita S; Giacomelli R; Gerli R; Bartoloni E;
    Clin Exp Rheumatol; 2020; 38 Suppl 126(4):53-56. PubMed ID: 33095137
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systemic involvement in primary Sjogren's syndrome evaluated by the EULAR-SS disease activity index: analysis of 921 Spanish patients (GEAS-SS Registry).
    Ramos-Casals M; Brito-Zerón P; Solans R; Camps MT; Casanovas A; Sopeña B; Díaz-López B; Rascón FJ; Qanneta R; Fraile G; Pérez-Alvarez R; Callejas JL; Ripoll M; Pinilla B; Akasbi M; Fonseca E; Canora J; Nadal ME; de la Red G; Fernández-Regal I; Jiménez-Heredia I; Bosch JA; Ayala MD; Morera-Morales L; Maure B; Mera A; Ramentol M; Retamozo S; Kostov B; ;
    Rheumatology (Oxford); 2014 Feb; 53(2):321-31. PubMed ID: 24162151
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is early-onset primary Sjögren's syndrome a worse prognosis form of the disease?
    Anquetil C; Hachulla E; Machuron F; Mariette X; Le Guern V; Vittecoq O; Dernis E; Larroche C; Dubost JJ; Perdriger A; Devauchelle-Pensec V; Fauchais AL; Morel J; Dieudé P; Rist S; Sene D; Gottenberg JE; Hatron PY
    Rheumatology (Oxford); 2019 Jul; 58(7):1163-1167. PubMed ID: 30561748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Prevalence of Sjögren's Syndrome in Rheumatoid Arthritis Patients and Their Clinical Features.
    Kim H; Cho SK; Kim HW; Han J; Kim Y; Hwang KG; Sung YK
    J Korean Med Sci; 2020 Nov; 35(45):e369. PubMed ID: 33230982
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In primary Sjögren's syndrome, HLA class II is associated exclusively with autoantibody production and spreading of the autoimmune response.
    Gottenberg JE; Busson M; Loiseau P; Cohen-Solal J; Lepage V; Charron D; Sibilia J; Mariette X
    Arthritis Rheum; 2003 Aug; 48(8):2240-5. PubMed ID: 12905478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-centromere antibody-positive Sjögren's syndrome: A distinct clinical subgroup?
    Lee KE; Kang JH; Lee JW; Wen L; Park DJ; Kim TJ; Park YW; Lee SS
    Int J Rheum Dis; 2015 Sep; 18(7):776-82. PubMed ID: 26179502
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sjogren's syndrome in Israel: primary versus secondary disease.
    Tishler M; Aharon A; Ehrenfeld M; Avni I; Bendet E; Bombardieri S; Yaron M; Shoenfeld Y
    Clin Rheumatol; 1994 Sep; 13(3):438-41. PubMed ID: 7835006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IgA immunoglobulin isotype of rheumatoid factor in primary Sjögren's syndrome.
    Maślińska M; Mańczak M; Kwiatkowska B; Ramsperger V; Shen L; Suresh L
    Rheumatol Int; 2021 Mar; 41(3):643-649. PubMed ID: 33496802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Occult primary Sjögren Syndrome in patients with interstitial pneumonia with autoimmune features.
    Auteri S; Alberti ML; Fernández ME; Blanco G; Rayá M; Guman G; Garbarino MC; Carballo OG; Caro F
    Respir Med; 2021 Jun; 182():106405. PubMed ID: 33894442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and predictors of Sjogren's syndrome in a prospective cohort of patients with aqueous-deficient dry eye.
    Liew MS; Zhang M; Kim E; Akpek EK
    Br J Ophthalmol; 2012 Dec; 96(12):1498-503. PubMed ID: 23001257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-Ro/SSA and anti-La/SSB autoantibodies in the tear fluid of patients with Sjögren's syndrome.
    Toker E; Yavuz S; Direskeneli H
    Br J Ophthalmol; 2004 Mar; 88(3):384-7. PubMed ID: 14977774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Potential Role for Early Biomarker Testing as Part of a Modern, Multidisciplinary Approach to Sjögren's Syndrome Diagnosis.
    Beckman KA; Luchs J; Milner MS; Ambrus JL
    Adv Ther; 2017 Apr; 34(4):799-812. PubMed ID: 28283891
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Childhood-onset of primary Sjögren's syndrome: phenotypic characterization at diagnosis of 158 children.
    Ramos-Casals M; Acar-Denizli N; Vissink A; Brito-Zerón P; Li X; Carubbi F; Priori R; Toplak N; Baldini C; Faugier-Fuentes E; Kruize AA; Mandl T; Tomiita M; Gandolfo S; Hashimoto K; Hernandez-Molina G; Hofauer B; Mendieta-Zerón S; Rasmussen A; Sandhya P; Sene D; Trevisani VFM; Isenberg D; Sundberg E; Pasoto SG; Sebastian A; Suzuki Y; Retamozo S; Xu B; Giacomelli R; Gattamelata A; Bizjak M; Bombardieri S; Loor-Chavez RE; Hinrichs A; Olsson P; Bootsma H; Lieberman SM;
    Rheumatology (Oxford); 2021 Oct; 60(10):4558-4567. PubMed ID: 33493333
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systemic manifestations of primary Sjögren's syndrome out of the ESSDAI classification: prevalence and clinical relevance in a large international, multi-ethnic cohort of patients.
    Retamozo S; Acar-Denizli N; Rasmussen A; Horváth IF; Baldini C; Priori R; Sandhya P; Hernandez-Molina G; Armagan B; Praprotnik S; Kvarnstrom M; Gerli R; Sebastian A; Solans R; Rischmueller M; Pasoto SG; Valim V; Nordmark G; Kruize A; Nakamura H; Hofauer B; Giacomelli R; Fernandes Moça Trevisani V; Devauchelle-Pensec V; Atzeni F; Gheita TA; Consani-Fernández S; Szántó A; Sivils K; Gattamelata A; Danda D; Kilic L; Bartoloni E; Bombardieri S; Sánchez-Guerrero J; Wahren-Herlenius M; Mariette X; Ramos-Casals M; Brito-Zerón P;
    Clin Exp Rheumatol; 2019; 37 Suppl 118(3):97-106. PubMed ID: 31464664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The 2016 classification criteria for primary Sjogren's syndrome: what's new?
    Franceschini F; Cavazzana I; Andreoli L; Tincani A
    BMC Med; 2017 Mar; 15(1):69. PubMed ID: 28359271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aseptic meningitis as initial presentation of subclinical Sjögren's syndrome: Could the cerebrospinal fluid anti-Ro/SSA and anti-La/SSB antibody system be the culprit?
    Kurotaki K; Fujita M; Aizawa T; Tsugawa K; Tanaka H
    Mod Rheumatol Case Rep; 2022 Jun; 6(2):217-219. PubMed ID: 35134231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.